Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$24.9 - $40.26 $2.79 Million - $4.51 Million
-112,100 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$32.46 - $43.42 $1.23 Million - $1.65 Million
-37,900 Reduced 25.27%
112,100 $3.93 Million
Q1 2021

May 12, 2021

BUY
$38.94 - $50.85 $1.78 Million - $2.32 Million
45,700 Added 43.82%
150,000 $6.11 Million
Q4 2020

Feb 05, 2021

BUY
$37.65 - $63.77 $3.93 Million - $6.65 Million
104,300 New
104,300 $4.52 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Granite Point Capital Management, L.P. Portfolio

Follow Granite Point Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Granite Point Capital Management, L.P. with notifications on news.